Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.

Kleinegger F, Hofer E, Wodlej C, Golob-Schwarzl N, Birkl-Toeglhofer AM, Stallinger A, Petzold J, Orlova A, Krassnig S, Reihs R, Niedrist T, Mangge H, Park YN, Thalhammer M, Aigelsreiter A, Lax S, Garbers C, Fickert P, Rose-John S, Moriggl R, Rinner B, Haybaeck J.

Biochim Biophys Acta Mol Basis Dis. 2018 Nov 9;1865(2):308-321. doi: 10.1016/j.bbadis.2018.11.006. [Epub ahead of print]

2.

Can the classification of low-grade endometrial stromal tumors still be improved?

Matias-Guiu X, Davidson B, Lax SF.

Virchows Arch. 2018 Dec;473(6):663-664. doi: 10.1007/s00428-018-2474-2. Epub 2018 Oct 26. No abstract available.

PMID:
30367239
3.

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.

Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Lax SF, Marth C, Fiegl H, Zeimet AG.

Br J Cancer. 2018 Sep;119(6):683-692. doi: 10.1038/s41416-018-0217-4. Epub 2018 Aug 15.

PMID:
30111871
4.

Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jul 25:391. doi: 10.1007/s00428-018-2419-9. [Epub ahead of print]

PMID:
30043108
5.

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women.

Dittrich R, Kliesch S, Schüring A, Balcerek M, Baston-Büst DM, Beck R, Beckmann MW, Behringer K, Borgmann-Staudt A, Cremer W, Denzer C, Diemer T, Dorn A, Fehm T, Gaase R, Germeyer A, Geue K, Ghadjar P, Goeckenjan M, Götte M, Guth D, Hauffa BP, Hehr U, Hetzer F, Hirchenhain J, Hoffmann W, Hornemann B, Jantke A, Kentenich H, Kiesel L, Köhn FM, Korell M, Lax S, Liebenthron J, Lux M, Meißner J, Micke O, Nassar N, Nawroth F, Nordhoff V, Ochsendorf F, Oppelt PG, Pelz J, Rau B, Reisch N, Riesenbeck D, Schlatt S, Sender A, Schwab R, Siedentopf F, Thorn P, Wagner S, Wildt L, Wimberger P, Wischmann T, von Wolff M, Lotz L.

Geburtshilfe Frauenheilkd. 2018 Jun;78(6):567-584. doi: 10.1055/a-0611-5549. Epub 2018 Jun 25.

6.

Miniseries of reviews: gynecological pathology.

Lax SF.

Virchows Arch. 2018 Jun;472(6):883-884. doi: 10.1007/s00428-018-2385-2. No abstract available.

PMID:
29862419
7.

Environmental Sources of Bacteria Differentially Influence Host-Associated Microbial Dynamics.

Cardona C, Lax S, Larsen P, Stephens B, Hampton-Marcell J, Edwardson CF, Henry C, Van Bonn B, Gilbert JA.

mSystems. 2018 May 29;3(3). pii: e00052-18. doi: 10.1128/mSystems.00052-18. eCollection 2018 May-Jun.

8.

The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Raspollini MR, Lax SF, McCluggage WG.

Virchows Arch. 2018 Jul;473(1):45-54. doi: 10.1007/s00428-018-2372-7. Epub 2018 May 24. Review.

PMID:
29799071
9.

Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, Glenn McCluggage W, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):937-938. doi: 10.1007/s00428-018-2380-7. Erratum in: Virchows Arch. 2018 Jul 25;:391.

PMID:
29789924
10.

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Doo NW, Giles GG, Southey MC, Milne RL, Offit K, Musinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF.

Cancer Res. 2018 Jul 15;78(14):4086-4096. doi: 10.1158/0008-5472.CAN-17-2900. Epub 2018 May 7.

11.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Radiother Oncol. 2018 Jun;127(3):404-416. doi: 10.1016/j.radonc.2018.03.003. Epub 2018 May 1.

PMID:
29728273
12.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4. Erratum in: Virchows Arch. 2018 May 23;:.

PMID:
29725757
13.

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer.

Wieser V, Gaugg I, Fleischer M, Shivalingaiah G, Wenzel S, Sprung S, Lax SF, Zeimet AG, Fiegl H, Marth C.

Oncotarget. 2018 Apr 3;9(25):17501-17511. doi: 10.18632/oncotarget.24770. eCollection 2018 Apr 3.

14.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.

PMID:
29688967
15.

WITHDRAWN: International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.

Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X.

Int J Gynecol Pathol. 2018 Apr 11. doi: 10.1097/PGP.0000000000000496. [Epub ahead of print]

PMID:
29521846
16.

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice.

Lax S, Rayes J, Thickett DR, Watson SP.

BMJ Open Respir Res. 2017 Nov 8;4(1):e000257. doi: 10.1136/bmjresp-2017-000257. eCollection 2017.

17.

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.

Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A.

Ann Oncol. 2018 May 1;29(5):1180-1188. doi: 10.1093/annonc/mdy058.

PMID:
29432521
18.

The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent.

Rayes J, Jadoui S, Lax S, Gros A, Wichaiyo S, Ollivier V, Denis CV, Ware J, Nieswandt B, Jandrot-Perrus M, Watson SP, Ho-Tin-Noé B.

Haematologica. 2018 Jun;103(6):e256-e258. doi: 10.3324/haematol.2017.182162. Epub 2018 Feb 1. No abstract available.

19.

The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.

Rayes J, Lax S, Wichaiyo S, Watson SK, Di Y, Lombard S, Grygielska B, Smith SW, Skordilis K, Watson SP.

Nat Commun. 2017 Dec 21;8(1):2239. doi: 10.1038/s41467-017-02402-6.

20.

Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Golob-Schwarzl N, Schweiger C, Koller C, Krassnig S, Gogg-Kamerer M, Gantenbein N, Toeglhofer AM, Wodlej C, Bergler H, Pertschy B, Uranitsch S, Holter M, El-Heliebi A, Fuchs J, Punschart A, Stiegler P, Keil M, Hoffmann J, Henderson D, Lehrach H, Reinhard C, Regenbrecht C, Schicho R, Fickert P, Lax S, Haybaeck J.

Oncotarget. 2017 Sep 5;8(60):101224-101243. doi: 10.18632/oncotarget.20642. eCollection 2017 Nov 24.

21.

Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.

Rogatsch M, Schmid J, Lax S, Uranitsch M, Schmid-Zalaudek K, Giuffrida R, Zalaudek I.

Eur J Cancer. 2018 Feb;90:146-148. doi: 10.1016/j.ejca.2017.11.008. Epub 2017 Dec 11. No abstract available.

PMID:
29237537
22.

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Kessler SM, Lederer E, Laggai S, Golob-Schwarzl N, Hosseini K, Petzold J, Schweiger C, Reihs R, Keil M, Hoffmann J, Mayr C, Kiesslich T, Pichler M, Kim KS, Rhee H, Park YN, Lax S, Obrist P, Kiemer AK, Haybaeck J.

Oncotarget. 2017 Sep 21;8(52):89736-89745. doi: 10.18632/oncotarget.21116. eCollection 2017 Oct 27.

23.

Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse.

Lax S, Rayes J, Wichaiyo S, Haining EJ, Lowe K, Grygielska B, Laloo R, Flodby P, Borok Z, Crandall ED, Thickett DR, Watson SP.

Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1016-L1029. doi: 10.1152/ajplung.00023.2017. Epub 2017 Aug 24.

24.

Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.

Deinlein T, Lax SF, Schwarz T, Giuffrida R, Schmid-Zalaudek K, Zalaudek I.

Eur J Cancer. 2017 Sep;83:99-102. doi: 10.1016/j.ejca.2017.06.022. Epub 2017 Jul 19. Review. No abstract available.

PMID:
28734147
25.

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.

Kommoss S, Hartkopf AD, Krämer B, Bunz AK, Grevenkamp F, Kommoss F, Pasternak J, Arbabi SM, Wallwiener M, Staebler A, Lax SF, Brucker SY, Taran FA.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2183-2188. doi: 10.1007/s00432-017-2474-7. Epub 2017 Jul 14.

PMID:
28710714
26.

Bacterial colonization and succession in a newly opened hospital.

Lax S, Sangwan N, Smith D, Larsen P, Handley KM, Richardson M, Guyton K, Krezalek M, Shogan BD, Defazio J, Flemming I, Shakhsheer B, Weber S, Landon E, Garcia-Houchins S, Siegel J, Alverdy J, Knight R, Stephens B, Gilbert JA.

Sci Transl Med. 2017 May 24;9(391). pii: eaah6500. doi: 10.1126/scitranslmed.aah6500.

27.

[Hereditary breast and ovarian cancer].

Lax SF.

Pathologe. 2017 May;38(3):149-155. doi: 10.1007/s00292-017-0298-5. Review. German.

PMID:
28500412
28.

Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.

Tiran V, Stanzer S, Heitzer E, Meilinger M, Rossmann C, Lax S, Tsybrovskyy O, Dandachi N, Balic M.

PLoS One. 2017 Apr 19;12(4):e0175223. doi: 10.1371/journal.pone.0175223. eCollection 2017.

29.

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Schütte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V, Worth CL, Schweiger C, Liebs S, Lange M, Warnatz HJ, Butcher LM, Barrett JE, Sultan M, Wierling C, Golob-Schwarzl N, Lax S, Uranitsch S, Becker M, Welte Y, Regan JL, Silvestrov M, Kehler I, Fusi A, Kessler T, Herwig R, Landegren U, Wienke D, Nilsson M, Velasco JA, Garin-Chesa P, Reinhard C, Beck S, Schäfer R, Regenbrecht CR, Henderson D, Lange B, Haybaeck J, Keilholz U, Hoffmann J, Lehrach H, Yaspo ML.

Nat Commun. 2017 Feb 10;8:14262. doi: 10.1038/ncomms14262.

30.

Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.

Kommoss S, Kommoss F, Diebold J, Lax S, Schmidt D, Staebler A, du Bois A, Pfisterer J.

Br J Cancer. 2017 Jan;116(3):287-292. doi: 10.1038/bjc.2016.416. Epub 2016 Dec 22.

31.

Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications.

Grevenkamp F, Kommoss F, Kommoss F, Lax S, Fend F, Wallwiener D, Schönfisch B, Krämer B, Brucker SY, Taran FA, Staebler A, Kommoss S.

Int J Gynecol Cancer. 2017 Feb;27(2):289-296. doi: 10.1097/IGC.0000000000000870.

PMID:
27922981
32.

Pathology of Endometrial Carcinoma.

Lax SF.

Adv Exp Med Biol. 2017;943:75-96.

PMID:
27910065
33.

[Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].

Lax SF, Horn LC, Löning T.

Pathologe. 2016 Nov;37(6):573-584. Review. German.

PMID:
27770187
34.

[Cervical cancer : Update on morphology].

Horn LC, Brambs CE, Handzel R, Lax S, Sändig I, Schmidt D, Schierle K.

Pathologe. 2016 Nov;37(6):542-548. German.

PMID:
27766382
35.

[Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Lax SF, Tamussino KF, Lang PF.

Pathologe. 2016 Nov;37(6):549-556. Review. German.

PMID:
27757531
36.

[Uterine pathology].

Lax SF.

Pathologe. 2016 Nov;37(6):499. German. No abstract available.

PMID:
27757530
37.

[New features in the 2014 WHO classification of uterine neoplasms].

Lax SF.

Pathologe. 2016 Nov;37(6):500-511. Review. German.

PMID:
27738815
38.

[Endometritis : Rare disease with clinical importance?]

Lax SF.

Pathologe. 2016 Nov;37(6):521-525. German.

PMID:
27738813
40.

L1CAM: amending the "low-risk" category in endometrial carcinoma.

Kommoss F, Kommoss F, Grevenkamp F, Bunz AK, Taran FA, Fend F, Brucker SY, Wallwiener D, Schönfisch B, Greif K, Lax S, Staebler A, Kommoss S.

J Cancer Res Clin Oncol. 2017 Feb;143(2):255-262. doi: 10.1007/s00432-016-2276-3. Epub 2016 Sep 30.

PMID:
27695947
41.

[Meeting of the Gynecological and Breast Pathology Working Group of the German Society of Pathology 2016].

Lax SF.

Pathologe. 2016 Nov;37(Suppl 2):233-234. German. No abstract available.

PMID:
27638534
42.

Vitamin D Deficiency in Human and Murine Sepsis.

Parekh D, Patel JM, Scott A, Lax S, Dancer RC, D'Souza V, Greenwood H, Fraser WD, Gao F, Sapey E, Perkins GD, Thickett DR.

Crit Care Med. 2017 Feb;45(2):282-289. doi: 10.1097/CCM.0000000000002095.

43.

[Meeting of the working group on gynecological and breast pathology of the German Society of Pathology 2015].

Lax SF.

Pathologe. 2015 Nov;36 Suppl 2:219-20. doi: 10.1007/s00292-015-0062-7. German. No abstract available.

PMID:
26742950
44.

Microbial community assembly and metabolic function during mammalian corpse decomposition.

Metcalf JL, Xu ZZ, Weiss S, Lax S, Van Treuren W, Hyde ER, Song SJ, Amir A, Larsen P, Sangwan N, Haarmann D, Humphrey GC, Ackermann G, Thompson LR, Lauber C, Bibat A, Nicholas C, Gebert MJ, Petrosino JF, Reed SC, Gilbert JA, Lynne AM, Bucheli SR, Carter DO, Knight R.

Science. 2016 Jan 8;351(6269):158-62. doi: 10.1126/science.aad2646. Epub 2015 Dec 10.

45.

Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.

Hitchcock JR, Cook CN, Bobat S, Ross EA, Flores-Langarica A, Lowe KL, Khan M, Dominguez-Medina CC, Lax S, Carvalho-Gaspar M, Hubscher S, Rainger GE, Cobbold M, Buckley CD, Mitchell TJ, Mitchell A, Jones ND, Van Rooijen N, Kirchhofer D, Henderson IR, Adams DH, Watson SP, Cunningham AF.

J Clin Invest. 2015 Dec;125(12):4429-46. doi: 10.1172/JCI79070. Epub 2015 Nov 16.

46.

The Influence of Age and Gender on Skin-Associated Microbial Communities in Urban and Rural Human Populations.

Ying S, Zeng DN, Chi L, Tan Y, Galzote C, Cardona C, Lax S, Gilbert J, Quan ZX.

PLoS One. 2015 Oct 28;10(10):e0141842. doi: 10.1371/journal.pone.0141842. eCollection 2015.

47.

GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.

Kargl J, Andersen L, Hasenöhrl C, Feuersinger D, Stančić A, Fauland A, Magnes C, El-Heliebi A, Lax S, Uranitsch S, Haybaeck J, Heinemann A, Schicho R.

Br J Pharmacol. 2016 Jan;173(1):142-54. doi: 10.1111/bph.13345. Epub 2015 Nov 25.

48.

Athletic equipment microbiota are shaped by interactions with human skin.

Wood M, Gibbons SM, Lax S, Eshoo-Anton TW, Owens SM, Kennedy S, Gilbert JA, Hampton-Marcell JT.

Microbiome. 2015 Jun 19;3:25. doi: 10.1186/s40168-015-0088-3. eCollection 2015.

49.

Forensic analysis of the microbiome of phones and shoes.

Lax S, Hampton-Marcell JT, Gibbons SM, Colares GB, Smith D, Eisen JA, Gilbert JA.

Microbiome. 2015 May 12;3:21. doi: 10.1186/s40168-015-0082-9. eCollection 2015.

50.

Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak.

Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C, Ward M, Muldoon JP, Singer M, An G, Umanskiy K, Konda V, Shakhsheer B, Luo J, Klabbers R, Hancock LE, Gilbert J, Zaborina O, Alverdy JC.

Sci Transl Med. 2015 May 6;7(286):286ra68. doi: 10.1126/scitranslmed.3010658.

Supplemental Content

Support Center